- Home
- KROS vs IQI Comparison
KROS vs IQI Comparison
Compare KROS & IQI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KROS
- IQI
- Stock Information
- Founded
- KROS 2015
- IQI 1992
- Country
- KROS United States
- IQI United States
- Employees
- KROS N/A
- IQI N/A
- Industry
- KROS Biotechnology: Pharmaceutical Preparations
- IQI Finance Companies
- Sector
- KROS Health Care
- IQI Finance
- Exchange
- KROS Nasdaq
- IQI Nasdaq
- Market Cap
- KROS 565.0M
- IQI 498.7M
- IPO Year
- KROS 2020
- IQI N/A
- Fundamental
- Price
- KROS $15.91
- IQI $10.01
- Analyst Decision
- KROS Buy
- IQI
- Analyst Count
- KROS 14
- IQI 0
- Target Price
- KROS $20.56
- IQI N/A
- AVG Volume (30 Days)
- KROS 424.2K
- IQI 162.1K
- Earning Date
- KROS 11-05-2025
- IQI 01-01-0001
- Dividend Yield
- KROS N/A
- IQI 4.61%
- EPS Growth
- KROS N/A
- IQI N/A
- EPS
- KROS 0.47
- IQI N/A
- Revenue
- KROS $232,844,000.00
- IQI N/A
- Revenue This Year
- KROS $6,657.47
- IQI N/A
- Revenue Next Year
- KROS N/A
- IQI N/A
- P/E Ratio
- KROS $34.14
- IQI N/A
- Revenue Growth
- KROS 85820.30
- IQI N/A
- 52 Week Low
- KROS $9.12
- IQI $8.05
- 52 Week High
- KROS $72.37
- IQI $10.00
- Technical
- Relative Strength Index (RSI)
- KROS 54.08
- IQI 69.46
- Support Level
- KROS $15.50
- IQI $9.89
- Resistance Level
- KROS $16.44
- IQI $9.95
- Average True Range (ATR)
- KROS 0.57
- IQI 0.06
- MACD
- KROS -0.01
- IQI -0.01
- Stochastic Oscillator
- KROS 59.87
- IQI 92.00
About KROS Keros Therapeutics Inc.
Keros Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from hematological, pulmonary, and cardiovascular disorders with high unmet medical needs. The company's protein therapeutic product candidate, KER-050, is being developed for the treatment of low blood cells counts, or cytopenias, including anemia and thrombocytopenia, in patients with myelodysplastic syndromes, or MDS, and in patients with myelofibrosis.
About IQI Invesco Quality Municipal Income Trust
Invesco Quality Municipal Income Trust is a diversified, closed-end management investment company. Its investment objective is to provide current income which is exempt from federal income tax.